The first licensed agent, talimogene laherparepvec (T-VEC), administered intratumorally, replicates within tumours to lyse infected cells while expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) to prime systemic immunity
Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes
In any case, patients should not decide by themselves to start a GLP-1 pill a doctor review is critical to ensure the treatment is safe and appropriate for the individual
Cline MG, Burns KM, Coe JB, et al
Its like he was saying, No, youre going to sit here and stay quiet, youre not going to use your voice or your presence . After her weight loss, I have so much more confidence to walk in my calling, Espino said